Kamagra repose sur le sildénafil comme principe actif, avec un mode d’action identique à celui du Viagra. La forme galénique en gel oral permet une absorption plus rapide et une concentration plasmatique maximale plus précoce que les comprimés. Le mécanisme implique l’inhibition compétitive de la PDE5, entraînant une relaxation musculaire lisse locale et une vasodilatation ciblée. La demi-vie courte, environ 4 heures, limite la durée d’action. L’élimination se fait après métabolisme hépatique, impliquant majoritairement le CYP3A4. L’incidence d’effets indésirables comprend céphalées, rougeurs et congestion nasale, de façon transitoire. Dans les comparatifs pharmacologiques, acheter kamagra sans ordonnance est associé aux présentations galéniques alternatives disponibles.

Ursofalk.cms.net.cn

1995-2006 Tsinghua Tongfang Optical Disc Co., Ltd. All rights reserved. Herald of Medicine Vol124 No12 February 2005 Beuers U , Boyer J L , Paumgart ner G1 Ursodeoxycholic acid in cho2 lestasis: potential mechanisms of action and t herapeutic application [J ]1 Hepatology , 1998 , 28 (6) : 1449 - 14531 Poupon R , Chazouilleres O , Poupon R E1 Chronic cholestatic dis2 eases[J ]1 J Hepatol , 2000 ,32 (Suppl 1) : 129 - 1401 Van C M , Elerink R P , Groen A K , et al1 Effects of ursodeoxy2 cholate and cholate feeding on liver disease in FVB mice wit h a disrupted mdr2 P2glycoprotein gene [J ] 1 Gast roenterology , 1996 , Paumgart ner G , Beuers U1 Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and t herapeutic use revisited [ J ] 1 Hepatology , 2002 , 36 (3) : 525 - 5311 Alpini G , Baiochchi l , Glaster S , et al1 Ursodeoxycholate and taur2 oursodeoxycholate inhibit cholangiocyte growt h and secretion of BDL rates t hrough activation of P KC alpha [J ] 1 Hepatology , 2002 , 35 Beuers U , Bilzer M , Chittatt u A , et al1 Tauroursodeoxycholic acid insert s t he apical conjugate export pump , Mrp2 , into canalicular membranes and stimulates organic anion secretion by protein kinase c2dependent mechanisms in cholestatic rat liver [ J ] 1 Hepatology , Fichert P , Zollner G , Fuchsbichler A , et al1 Effects of ursodeo2 xycholic and cholic acid feeding on hepatocellular t ransporter expression in mouse liver [ J ] 1 Gast roenterology , 2001 , 121 ( 1 ) : Kurz A K , Graf D , Schmitt M , et al1 Tauroursodeoxycholate2 1995-2006 Tsinghua Tongfang Optical Disc Co., Ltd. All rights reserved. induced choleresis involves p38 ( MAP K) activation and t ranslocation Brites D , Rodrigues C M , Oliveira N , et al1 Correction of maternal of t he bile salt export pump in rat s [J ] 1 Gast roenterology , 2001 , serum bile acid profile during ursodeoxycholic acid t herapy in cholestasis of pregnancy[J ]1 J Hepatol , 1998 , 28 (1) : 91 - 981 Noe J , Hagenbuch B , Meier P J , et al1 Characterization of the Brites D , Rodrigues C M1 Elevated levels of bile acids in colostrum mouse bile salt export pump over expressed in t he baculovirus of patient s wit h cholestasis of pregnancy are decreased following system[J ]1 Hepatology , 2001 , 33 (5) : 1223 - 12311 ursodeoxycholic acid t herapy[J ]1 J Hepatol , 1998 , 29 (5) : 743 - Lazaridis K N , Gores G J , Lindor K D1 Ursodeoxycholic acid mec2 hanisms of action and clinical use in hepatobiliary disorders [J ] . J Rodrigues C M , Marin J G , Brites D1 Bile acid patterns in meco2 Hepatol , 2001 , 35 (1) : 134 - 1461 nium are influenced by cholestasis of pregnancy and not altered by Benz C , Angermuller S , Tox U , et al1 Effect of taurorusodeoxy2 ursodeoxycholic acid t reat ment [J ]1 Gut , 1999 , 45 (3) : 446 - 4521 cholic acid on bile2acid2induced apoptosis and cytolysis in rat Mazzella G , Rizzo N , Azzaroli F , et al1 Ursodeoxycholic acid admi2 hepatocytes [J ]1 J Hepato , 1998 , 28 (1) : 99 - 1061 nist ration in patient s wit h cholestasis of pregnancy : effect s on Rodrigues C , Fan G , Wong P , et al1 Ursodeoxycholic acid may primary bile acids in babies and mot hers[J ]1 Hepatology , 2001 , 33 mitochondrial t ransmembrane potential and reactive oxygen species Williamson C , Gorelid J , Eaton B M , et al1 The bile acid taurocho2 production[J ]1 Mol Med , 1998 ,4 (3) : 165 - 1781 late impairs rat cardiomyocyte function : a proposed mechanism for Qiao L , Yacoub A , St uder E , et al1 Inhibition of the MAP K and int rauterine fetal deat h in obstet ric cholestasis [J ]1 Cli n Sci , 2001 , PI3 K pat hways enhances UDCA2induced apoptosis in primary rodent hepatocytes[J ]1 Hepatology , 2002 , 35 (4) : 779 - 7891 Lee W Y , Han S H , Cho T S , et al1 Effect of ursodeoxycholic acid Laifer S A , Stiller R J , Siddiqui D S , et al1 Ursodeoxycholic acid on ischemia/ reperfusion injury in isolated rat heart [J ]1 A rch Pharm for t he t reat ment of int rahepatic cholestasis of pregnancy [ J ] 1 J M atern Fet al Med , 2001 , 10 (2) : 131 - 1351 Serrano M A , Brites D , Larena M G , et al1 Beneficial effect of Berkane N , Cocheton J J , Brehier D , et al1 Ursodeoxycholic acid in urso2deoxycholic acid on alterations induced by cholestasis of int rahepatic cholestasis of pregnancy1 A retrospective study of 19 pregnancy in bile acid t ransport across t he human placenta [J ] 1 J cases[J ]1 Acta Obstet Gynecol Scand , 2000 , 79 (11) : 941 - 946 1 Hepatol , 1998 , 28 (5) : 829 - 8391 Nicast ri P L , Diaferia A , Tartagni M1 A randomised placebocontr2 Zapata R1 UDCA in the treatment of intrahepatic cholestasis of preg2 olled t rial of ursodeoxycholic acid and sadenosylmet hionine in t he nancy1 A 102year experience on it efficacy , safety and the perinatal t reat ment of int rahepatic cholestasis of pregnancy [J ] 1 B r J Obstet outcome[J ]1 Gast roentenrology , 2000 ,118 (Suppl 4) : 1001 Gy naecol , 1998 , 105 (11) : 1205 - 1207 1 1995-2006 Tsinghua Tongfang Optical Disc Co., Ltd. All rights reserved.

Source: http://ursofalk.cms.net.cn/DocLib/%E7%86%8A%E5%8E%BB%E6%B0%A7%E8%83%86%E9%85%B8%E6%B2%BB%E7%96%97%E5%A6%8A%E5%A8%A0%E6%9C%9F%E8%82%9D%E5%86%85%E8%83%86%E6%B1%81%E6%B7%A4%E7%A7%AF%E7%97%87%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95.PDF